Walsh expects that rate would drop significantly if Florida ends the mandates, putting more children at risk. Florida’s ...

The latest update is out from Arbutus Biopharma ( (ABUS) ).

Pfizer and BioNTech report that their updated mRNA COVID-19 vaccine for the 2025–2026 season produced strong immune responses ...

Truist Securities called pumitamig’s data on Monday “very reassuring,” given the consistency between its performance in ...

The Bristol Myers-partnered bispecific antibody kept small cell lung cancer under control in participants enrolled in a Phase 2 trial.

In August, the Food and Drug Administration had approved Pfizer-BioNTech’s new COVID-19 vaccine based on preclinical data.

The latest update is out from BioNTech SE ( (BNTX) ).

Pfizer and BioNTech's LP.8.1 COVID-19 vaccine boosts antibodies 4-fold in high-risk adults, with no new safety concerns ...

The companies said their updated shot spurred an increase in neutralizing antibodies against currently circulating strains, ...

PD-L1xVEGF-A bispecific antibody pumitamig (BNT327/BMS986545) plus chemotherapy continues to show encouraging antitumor activity in patients ...

BioNTech’s chief medical officer, Özlem Türeci, M.D., described the findings as “very consistent” with the drug’s previous ...

A next-generation cancer immunotherapy by BioNTech and partner Bristol Myers Squibb led to encouraging tumour shrinkage in a ...